250 related articles for article (PubMed ID: 33912986)
1. Cryoablation of renal tumors: long-term follow-up from a multicenter experience.
Stacul F; Sachs C; Giudici F; Bertolotto M; Rizzo M; Pavan N; Balestreri L; Lenardon O; Pinzani A; Pola L; Cicero C; Celia A; Cova MA
Abdom Radiol (NY); 2021 Sep; 46(9):4476-4488. PubMed ID: 33912986
[TBL] [Abstract][Full Text] [Related]
2. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center.
Cernic S; Marrocchio C; Ciabattoni R; Fiorese I; Stacul F; Giudici F; Rizzo M; Cova MA
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33804740
[No Abstract] [Full Text] [Related]
4. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan.
Lin YT; Hung SW; Liu MC; Chiu KY; Chai JW; Lin JC
Anticancer Res; 2023 Apr; 43(4):1699-1708. PubMed ID: 36974775
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
9. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.
Ahrar K; Ahrar JU; Javadi S; Pan L; Milton DR; Wood CG; Matin SF; Stafford RJ
Invest Radiol; 2013 Jun; 48(6):437-44. PubMed ID: 23511191
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases.
Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A
Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
14. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.
De Marini P; Cazzato RL; Garnon J; Dalili D; Leonard-Lorant I; Leclerc L; Autrusseau PA; Auloge P; Weiss J; Tricard T; Lang H; Gangi A
Diagn Interv Imaging; 2021 Sep; 102(9):531-538. PubMed ID: 33931365
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic Cryoablation for Renal Cell Carcinoma: 100-Month Oncologic Outcomes.
Caputo PA; Ramirez D; Zargar H; Akca O; Andrade HS; O'Malley C; Remer EM; Kaouk JH
J Urol; 2015 Oct; 194(4):892-6. PubMed ID: 25912493
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation.
Marion JT; Schmitz JJ; Schmit GD; Kurup AN; Welch BT; Pasternak JJ; Boorjian SA; Leibovich BC; Atwell TD; Thompson RH
J Vasc Interv Radiol; 2020 Aug; 31(8):1249-1255. PubMed ID: 32457011
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
